Ai Mediq veröffentlicht eine Übersetzung der Veröffentlichung von Prof. Oleg S. Glazachev für RBC.RU zu den Auswirkungen von COVID-19 und dem therapeutischen Potenzial der Anwendung des ReOxy-Geräts zur Rehabilitation der Patienten.
Ai Mediq S.A. freut sich, die neue Phase der wissenschaftlichen Zusammenarbeit mit dem Universitätsklinikum Hamburg-Eppendorf (UKE) bekannt zu geben.
Presentation of the Intermittent Hypoxic Training Method in one of the well-known Liliane Goschy-FRITZ Institute in Baden-Baden, Germany on the 15th if July 2020.
Currently, all efforts are focused on patients with acute diseases. All hospitals are crowded with severe patients with COVID-19 who need emergency care to save their lives.
This February our leading instrument for delivering Interval Hypoxic Hyperoxic Therapy - ReOxy is presented to the attention of the general public in Bangkok, Thailand during the 24th Regional Conference of Dermatology taking place from 25th till 28th of February.
Yesterday, on 30th of January 2020 was the final day both of one of the largest medical trade-shows Arab Health and Official Mission of Grand Duchy of Luxembourg to the United Arab Emirates. Ai Mediq was thrilled to take part in both of these remarkable events with very promising outcomes.
Die offizielle Geschäftsmission des Großherzogtums Luxemburg hat gestern, am 28. Januar, die Messe Arab Health 2020 besucht. Unter der Leitung…
Ai Mediq announces it’s participation in largest professional event in MENA region – Arab Health 2020. The event will...
On 21st of January 2020, Luxinnovation has held a remarkable event "Health Technologies @ Luxembourg 2020" focused on new medical technologies developed by Luxembourg enterprises.
